NDC 0069-0227 – Lorbrena
Lorlatinib 25 mg/1 · Tablet, Film Coated · Oral
Product NDC0069-0227
Product details
- Brand name
- Lorbrena
- Generic name
- Lorlatinib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA210868
- Marketed since
- November 19, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Lorlatinib 25 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0227-01 | 30 TABLET, FILM COATED in 1 BOTTLE (0069-0227-01) | Nov 19, 2018 |
| 0069-0227-03 | 120 TABLET, FILM COATED in 1 BOTTLE (0069-0227-03) | Jan 3, 2025 |